What Is The Leading Driver Behind Expansion Of Telehealth Services Driving The Market Growth Due To Increasing Remote Patient Care Needs Market Expansion in 2025

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Industry Market Size Be by 2025?
The market encompassing artificial intelligence (AI) augmented remote intravenous (IV) patient surveillance is experiencing a swift upward trajectory, expanding from a valuation of $1.39 billion in 2024 to an anticipated $1.69 billion in 2025, reflecting a robust compound annual growth rate (CAGR) of 21.8%; this expansion throughout the past period is largely fueled by the increasing incidence of long-term conditions necessitating sustained infusions, the transition of infusion services away from traditional hospital settings to ambulatory care centers, the proliferation of biologic treatments in fields like oncology and immunology, the greater acceptance of remote healthcare paradigms following the pandemic, and the scarcity of nursing staff compelling a greater reliance on remote supervision methods.

What's the Long-Term Growth Forecast for the Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Size Through 2029?
Anticipation surrounds the forthcoming period for the segment dealing with remote intravenous (IV) monitoring systems augmented by artificial intelligence (AI), where substantial expansion is projected. This market is slated to achieve a valuation of $3.67 billion by the year 2029, reflecting a robust compound annual growth rate (CAGR) of 21.4%. A confluence of factors underpins this upward trajectory over the anticipated timeframe, including the broadening scope and adoption of "hospital at home" initiatives, the ongoing proliferation of specialized infusion therapies, particularly for cancer and autoimmune conditions, enduring shortages and elevated strain among nursing staff, the impetus provided by value-based payment models that incentivize superior safety records and patient results, and shifts in insurance provider strategies favoring the transfer of suitable infusion treatments to the home environment. Key developments shaping this market throughout the projection horizon involve the implementation of computer vision techniques for identifying instances of leakage or fluid accumulation outside the vein, the utilization of advanced optical sensing across multiple light spectra to detect subtle alterations in tissue near the catheter insertion point, the integration of edge AI directly onto sensor patches to enable localized data processing, the deployment of sophisticated predictive models designed to anticipate blockages, airborne bubbles within tubing, and irregularities in fluid flow, alongside efforts to ensure seamless data exchange with electronic health records via Fast Healthcare Interoperability Resources application programming interfaces.

View the full report here:
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-enhanced-remote-patient-intravenous-iv-monitoring-global-market-report

What Are the Key Growth Drivers Fueling the Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Expansion?
The ongoing expansion of telehealth services is anticipated to boost the trajectory of the market for artificial intelligence (AI) enhanced remote patient intravenous (IV) monitoring moving forward. Telehealth encompasses methods of healthcare service delivery that leverage digital means for remote medical consultations, oversight, and therapy, an accessibility surge having been facilitated by regulatory adjustments and reimbursement frameworks established during the COVID-19 pandemic, which rendered virtual care both practical and financially feasible for practitioners and those receiving care alike. This AI-powered apparatus for remote IV tracking bolsters telehealth by facilitating continuous, remote surveillance of patients' IV treatments, automating the identification of complications, furnishing clinicians with pertinent intelligence, and integrating smoothly with virtual platforms to guarantee prompt action, elevated patient security, and more streamlined handling of treatments administered at home or on an outpatient basis; for illustration, data from the US non-profit FAIR Health Inc. indicated a 7.3% national uptick in telehealth utilization in 2023 by April, moving from 5.5% of medical claim lines in December 2022 to 5.9% the following January, thus confirming that the proliferation of telehealth services serves as a catalyst for the expansion of the AI-enhanced remote patient IV monitoring sector.Proliferation Of Wearable Health Technologies Driving The Growth Of Market Due To Continuous Health Data Collection And Timely Patient InterventionThe onward march of wearable health technologies is projected to stimulate the expansion of the market for AI-enhanced remote patient IV monitoring in the coming period.Wearable health technologies consist of apparatus such as sophisticated fitness bands and smartwatches capable of monitoring various physiological indicators in real time.Their uptake is increasing, fueled by a growing societal focus on wellness, as individuals proactively scrutinize their health, track vital statistics, and seek instruments offering immediate insight into their physical condition.These devices facilitate remote IV monitoring by consistently gathering immediate physiological data from patients, analysis of which aids in spotting deviations, refining IV regimens, and enabling swift, individualized interventions without the necessity of constant face-to-face supervision; an example of this support is the investment, as reported in April 2025 by the UK House of Commons Library, wherein NIHR and UKRI jointly committed roughly USD 15 million (£11.5 million) across ten distinct research endeavors between 2023 and 2024, focused on developing wearables to enhance the autonomy of individuals contending with frailty or chronic physical impairments, thereby demonstrating how the spread of wearable tech propels the AI-enhanced remote patient IV monitoring market.Increasing Healthcare Expenditure Driving The Growth Market Due To Rising Investment In Advanced Medical TechnologiesThe escalation in overall healthcare spending is expected to be a major factor promoting the growth of the market for AI-enhanced remote patient IV monitoring going forward.Healthcare expenditure represents the totality of monetary resources allocated to medical services and associated products within a defined timeframe.This spending trajectory is upward, driven by the escalating need for sophisticated medical tools and services designed to improve patient outcomes, boost treatment effectiveness, and support the integration of AI-enabled remote monitoring solutions.Elevated healthcare spending provides the essential funding for advanced technologies, digital infrastructure build-out, and specialized personnel training required to achieve more efficient and precise patient care via AI-enhanced remote IV monitoring; as evidence, the US government agency, the Centers for Medicare & Medicaid Services, documented in June 2025 that national health expenditures in 2023 grew by 7.5%, reaching $4.9 trillion, which translated to an average of $14,570 per capita, constituting 17.6% of the Gross Domestic Product (GDP), with Medicare allocations specifically increasing by 8.1% to $1,029.8 billion, accounting for 21% of the total NHE, thus positioning augmented healthcare expenditure as a key driver for the AI-enhanced remote patient IV monitoring market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28921&type=smp

How Is the Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Segmented?
The artificial intelligence (ai)-enhanced remote patient intravenous (iv) monitoringmarket covered in this report is segmented -

1) By Component: Hardware, Software, Services
2) By Deployment Mode: On-Premises, Cloud-Based
3) By Application: Hospitals, Clinics, Homecare Settings, Ambulatory Surgical Centers, Other Applications
4) By End-User: Healthcare Providers, Patients

Subsegments:
1) By Hardware: Patient Monitoring Devices, Sensors And Infusion Pumps, Communication Devices, Data Storage Systems
2) By Software: Predictive Analytics Software, Clinical Decision Support Software, Remote Monitoring Software, Data Management Software
3) By Services: Implementation And Integration Services, Maintenance And Support Services, Training And Education Services, Remote Monitoring Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=28921&type=smp

Which Companies Are Leading the Charge in Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Innovation?
Major companies operating in the artificial intelligence (ai)-enhanced remote patient intravenous (iv) monitoring market are Medtronic plc, Siemens Healthineers AG, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Baxter International Inc., B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Epic Systems Corporation, ICU Medical Inc., InfuSystem Holdings Inc., AlayaCare Inc., Huma Therapeutics Ltd., Health Recovery Solutions Inc., Arcomed AG, VitalConnect Inc., Cloud DX Inc., Empatica S.r.l., AccuHealth Inc., Serum Tracker Inc.

Which Regions Are Leading the Global Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market in Revenue?
North America was the largest region in the artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=28921

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.